TGFBR1 and malignant colon neoplasm: Direct inhibition of CD8+ T cell trafficking by TGFβ was demonstrated in the MC38 and CT26 colon cancer models, whereby administration of the TGFβR1 kinase inhibitor galunisertib prior to therapy enhanced TGI due to 5-fluorouracil plus radiation.